AS

Abhinav Saxena

Active Director Director DIN 08105382
DIN 08105382 First appointment Mar 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value •••• Premium profile

About Abhinav Saxena

Data last updated:

Abhinav Saxena is a Director at Doshafix Drugs Private Limited (since 2018). The company operates in Healthcare. Doshafix Drugs Private Limited reported revenue of ₹6.6 Lakh (FY 2017).

DIN 08105382
Primary Designation Director
Industry Healthcare
First Appointment 27 Mar 2018
Oldest Company Age 11 yrs
Largest company Doshafix Drugs Private Limited · ₹6.6 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Doshafix Drugs Private Limited U24233UP2015PTC072085
Director27 Mar 20182015₹6.6 Lakh (FY 2017)Active

Board colleagues of Abhinav Saxena

NameDINCompanyDesignation
Anurag Saxena08024144Doshafix Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Doshafix Drugs Private Limited
Premium access

Shareholding and investment profile for Abhinav Saxena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhinav Saxena

Abhinav Saxena currently holds 1 directorship: Doshafix Drugs Private Limited (Director, since 27 Mar 2018, revenue ₹6.6 Lakh (FY 2017)).

Abhinav Saxena was first appointed on 27 Mar 2018 as Director at Doshafix Drugs Private Limited.

The current boards of Abhinav Saxena's companies include Anurag Saxena (Doshafix Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available